pharma · Moderate to severe pain associated with Osteoarthritis of the knee · Not applicable for phase I study
Grünenthal
Gruenenthal GmbH
Grünenthal trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.
Aachen, DE HQ
4,668 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Aachen, DE
- Employees
- 4,668
- Programs
- 3
- Drugs
- 5
- Patents
- 0
Grünenthal clinical trials
Registry index of 3 ClinicalTrials.gov studies linked to Grünenthal programs — each row shows trial ID, program name, phase, status, and indication.
Grünenthal trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Grünenthal.
Trial registry
-
CTIS ↗ - 2024-515709-24-00CTIS ↗
RTX-GRT7039, Naropin® 5 mg/ml Injektionslösung
Moderate to severe pain associated with Osteoarthritis of the knee
-
CTIS ↗